4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0002135296-26-000009
Options or other derivatives
- President and CEO acquired 1,036,923 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Casale Donn President and CEO | 2026-10-01 | Grant or award · Stock Option (right to buy) | +1,036,923 | 1,036,923 | D | ||
Loading xslF345X06/form4-10052026_081042.xml…